Remitz, Inc.
David Preiner is the Founder & CEO of Remitz, Inc., CEO of Medivolve, and Founder & CEO of Xenomics. David is also the Founder of Amino Therapeutics, Biotii Technologies, and Freedom Financial and Affiliates. Prior to their current roles, David worked as a Neurodiagnostics Tech at Boston Children's Hospital and as a Marketing Director at Source Lending. David has a diverse background in pharmaceuticals, technology, finance, and healthcare, with a strong track record of leadership and innovation in various industries.
This person is not in any teams
This person is not in any offices
Remitz, Inc.
As the leading provider of automated revenue recovery services, Remitz has leveraged data-driven analytics and industry-changing technologies to develop a unique approach to medical billing. Using sophisticated algorithms, Remitz is able to identify and submit claims that would otherwise go uncollected - driving smarter billing processes and maximizing profits for healthcare professionals nationwide.